First Light Diagnostics Forms World-Class International Clinical Advisory Board
Industry Experts to Support Development and Commercialization Chelmsford, MA (Newswire.com) – First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the establishment of a Clinical Advisory Board (CAB). The board is a growing list of members asked to participate based on world-renowned expertise…
Dr. Peter Kaspar Joins First Light Diagnostics Board of Directors
Chelmsford, MA, February 6, 2019 (Newswire.com) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Dr. Peter Kaspar to the company’s board of directors effective January 1, 2019. “Peter is one of the most respected executives in life sciences and…
First Light Diagnostics Invited to Speak at Boston Area Antibiotic Resistance Network
Company Presents New Method for Rapidly Determining the Effective Antibiotics to Treat Serious Infections Directly from Patient Samples Chelmsford, Massachusetts, January 24, 2019 (Newswire.com) – First Light Diagnostics, a developer of breakthrough automated diagnostic products for rapid, sensitive, and cost-effective diagnostic tests for life-threatening infections, today announced their recent participation at the 6th Annual Meeting of the…
First Light Diagnostics Closes $8.25 Million Series A-2 Financing
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced it has closed an oversubscribed $8.25 million Series A-2 financing. The financing includes new investment partners from Think.Health Ventures, 10x Group, and Beacon Angels, along with numerous new individual investors and continued participation from…
First Light Announces Company Name Change
Chelmsford, MA – January 7, 2019 — First Light Biosciences, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening antibiotic-resistant infections, today announced that effective immediately, the company is changing their name to First Light Diagnostics. The new name reflects the company’s evolution from development to commercialization of diagnostic solutions….
First Light Diagnostics Announces New Corporate Headquarters in Chelmsford, Massachusetts
New facility offers additional space, state of the art laboratory, added manufacturing capacity Chelmsford, Massachusetts, December 5, 2018 (Newswire.com) – First Light Diagnostics (formerly First Light Biosciences), a developer of breakthrough automated diagnostic products for rapid, sensitive, and cost-effective diagnostic tests for life-threatening infections, today announced its recent move to a new corporate headquarters in Chelmsford,…
First Light Diagnostics Develops Rapid Test for C. Difficile Toxin B. in Stool Samples
Results of Technical Study Presented at ASM Microbe 2018 Chelmsford, MA, November 27, 2018 (Newswire.com) – First Light Diagnostics (formerly First Light Biosciences), a developer of breakthrough automated diagnostic products for rapid, sensitive, and cost-effective diagnostic tests for life-threatening infections, today announced the results of their scientific poster, “A Rapid Single Molecule Counting Method Sensitively Detects Clostridium…
First Light Diagnostics Announces Peer-Reviewed Publication
Describing rapid and accurate immunoassay-based technology capable of counting single molecules using digital imaging without magnification Bedford, Massachusetts, October 25, 2018 (Newswire.com) – Bedford, Massachusetts, October 25, 2018 (Newswire) – First Light Diagnostics (formerly First Light Biosciences), a developer of breakthrough automated diagnostic products for rapid, sensitive, and cost-effective diagnostic tests for life-threatening infections today announced…
First Light Diagnostics Announces Funding from Biomedical Advanced Research and Development Authority (BARDA)
A contract extension representing $10.7 million over 2 years Bedford, MA – (October 11, 2018) – First Light Diagnostics (formerly First Light Biosciences), a developer of breakthrough automated diagnostic products for rapid, sensitive, and cost-effective diagnostic tests for life-threatening infections, announced today that BARDA has approved a $10.7 million extension of the Company’s multi-year contract…
First Light Diagnostics Develops a Novel Method for Rapidly Determining Effective Antibiotics for Treating Infections
Presenting Their Findings in a Scientific Poster Session at IDWeek BEDFORD, Mass., September 27, 2018 (Newswire.com) – First Light Diagnostics (formerly First Light Biosciences), a provider of innovative diagnostic tests for fighting life-threatening infections and combating the spread of antibiotic resistance, today announced they will be presenting a scientific poster detailing their novel MultiPath™ technology for…